Literature DB >> 14981084

Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides.

Andreas Gille1, Gerald H Lushington, Tung-Chung Mou, Michael B Doughty, Roger A Johnson, Roland Seifert.   

Abstract

Mammals express nine membranous adenylyl cyclase isoforms (ACs 1-9), a structurally related soluble guanylyl cyclase (sGC) and a soluble AC (sAC). Moreover, Bacillus anthracis and Bacillus pertussis produce the AC toxins, edema factor (EF), and adenylyl cyclase toxin (ACT), respectively. 2'(3')-O-(N-methylanthraniloyl)-guanosine 5'-[gamma-thio]triphosphate is a potent competitive inhibitor of AC in S49 lymphoma cell membranes. These data prompted us to study systematically the effects of 24 nucleotides on AC in S49 and Sf9 insect cell membranes, ACs 1, 2, 5, and 6, expressed in Sf9 membranes and purified catalytic subunits of membranous ACs (C1 of AC5 and C2 of AC2), sAC, sGC, EF, and ACT in the presence of MnCl(2). N-Methylanthraniloyl (MANT)-GTP inhibited C1.C2 with a K(i) of 4.2 nm. Phe-889 and Ile-940 of C2 mediate hydrophobic interactions with the MANT group. MANT-inosine 5'-[gamma-thio]triphosphate potently inhibited C1.C2 and ACs 1, 5, and 6 but exhibited only low affinity for sGC, EF, ACT, and G-proteins. Inosine 5'-[gamma-thio]triphosphate and uridine 5'-[gamma-thio]triphosphate were mixed G-protein activators and AC inhibitors. AC5 was up to 15-fold more sensitive to inhibitors than AC2. EF and ACT exhibited unique inhibitor profiles. At sAC, 2',5'-dideoxyadenosine 3'-triphosphate was the most potent compound (IC(50), 690 nm). Several MANT-adenine and MANT-guanine nucleotides inhibited sGC with K(i) values in the 200-400 nm range. UTP and ATP exhibited similar affinities for sGC as GTP and were mixed sGC substrates and inhibitors. The exchange of MnCl(2) against MgCl(2) reduced inhibitor potencies at ACs and sGC 1.5-250-fold, depending on the nucleotide and cyclase studied. The omission of the NTP-regenerating system from cyclase reactions strongly reduced the potencies of MANT-ADP, indicative for phosphorylation to MANT-ATP by pyruvate kinase. Collectively, AC isoforms and sGC are differentially inhibited by purine and pyrimidine nucleotides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14981084     DOI: 10.1074/jbc.M312560200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.

Authors:  Miriam Erdorf; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-29       Impact factor: 3.000

2.  Soluble adenylyl cyclase mediates nerve growth factor-induced activation of Rap1.

Authors:  Alexander M Stessin; Jonathan H Zippin; Margarita Kamenetsky; Kenneth C Hess; Jochen Buck; Lonny R Levin
Journal:  J Biol Chem       Date:  2006-04-20       Impact factor: 5.157

Review 3.  Role of soluble adenylyl cyclase in the heart.

Authors:  Jonathan Chen; Lonny R Levin; Jochen Buck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

4.  Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5'-triphosphates.

Authors:  Hesham Taha; Stefan Dove; Jens Geduhn; Burkhard König; Yuequan Shen; Wei-Jen Tang; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

5.  Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA.

Authors:  Martin Göttle; Stefan Dove; Frieder Kees; Jens Schlossmann; Jens Geduhn; Burkhard König; Yuequan Shen; Wei-Jen Tang; Volkhard Kaever; Roland Seifert
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

6.  Natural and engineered photoactivated nucleotidyl cyclases for optogenetic applications.

Authors:  Min-Hyung Ryu; Oleg V Moskvin; Jessica Siltberg-Liberles; Mark Gomelsky
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

Review 7.  Molecular details of cAMP generation in mammalian cells: a tale of two systems.

Authors:  Margarita Kamenetsky; Sabine Middelhaufe; Erin M Bank; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

8.  A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.

Authors:  Jenna L Wang; Jian-Xin Guo; Qi-Yuan Zhang; Jay J-Q Wu; Roland Seifert; Gerald H Lushington
Journal:  Bioorg Med Chem       Date:  2007-02-11       Impact factor: 3.641

9.  Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate.

Authors:  Melanie Hübner; Anshuman Dixit; Tung-Chung Mou; Gerald H Lushington; Cibele Pinto; Andreas Gille; Jens Geduhn; Burkhard König; Stephen R Sprang; Roland Seifert
Journal:  Mol Pharmacol       Date:  2011-04-15       Impact factor: 4.436

10.  Pharmacological distinction between soluble and transmembrane adenylyl cyclases.

Authors:  Jacob L Bitterman; Lavoisier Ramos-Espiritu; Ana Diaz; Lonny R Levin; Jochen Buck
Journal:  J Pharmacol Exp Ther       Date:  2013-10-03       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.